Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity

Molecular Cancer Research

Volumn 9, Issue 8, 2011, Pages 1030-1041

  Ray, Alpana ^a   Dhar, Srijita ^a   Ray, Bimal K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; SERUM AMYLOID A ACTIVATING FACTOR 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052016595     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0598     Document Type: Article

References (53)

1. Engels K., Fox S.B., Whitehouse R.M., Gatter K.C., Harris A.L. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 1997;181:207-212 (Pubitemid 27087287)
2. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36:127-137
3. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 2002;29:10-14
4. Yoshiji H., Gomez D.E., Shibuya M., Thorgeirsson U.P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996;56:2013-2016 (Pubitemid 26119899)
5. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Guidi A.J., Dvorak H.F., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathol 1995;26:86-91.
6. Van der Auwera I., Van Laere S.J., Van den Eynden G.G., Benoy I., Van Dam P., Colpaert C.G., et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 2004;10:7965-7971 (Pubitemid 39587537)
7. Jacobs E.J., Feigelson H.S., Bain E.B., Brady K.A., Rodriguez C., Stevens V.L., et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006;8:R22.
8. Giantonio B.J., Catalano P.J., Meropol N.J., O'Dwyer P.J., Mitchell E.P., Alberts S.R., et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007;25:1539-1544 (Pubitemid 46733080)
9. O'Dwyer P.J. The present and future of angiogenesis-directed treatments of colorectal cancer. Oncologist 2006;11:992-998 (Pubitemid 44564807)
10. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613 (Pubitemid 26272112)
11. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000;156:965-976 (Pubitemid 30626954)
12. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 50 enhancer. Circ Res 1995;77:638-643
13. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003;9:677-684 (Pubitemid 36749216)
14. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001;15:2865-2876 (Pubitemid 33042056)
15. Feldkamp M.M., Lau N., Rak J., Kerbel R.S., Guha A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 1999;81:118-124 (Pubitemid 29124206)
16. Mazure N.M., Chen E.Y., Laderoute K.R., Giaccia A.J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997;90:3322-3331 (Pubitemid 27473400)
17. Shibata A., Nagaya T., Imai T., Funahashi H., Nakao A., Seo H. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDAMB-231 breast cancer cells. Breast Cancer Res Treat 2002;73:237-243 (Pubitemid 34712997)
18. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redoxinduced changes. J Biol Chem 1997;272:22642-22647 (Pubitemid 27386079)
19. Pages G., Pouyssegur J. Transcriptional regulation of the vascular endothelial growth factor gene-a concert of activating factors. Cardiovasc Res 2005;65:564-573 (Pubitemid 40138977)
20. Ray B.K., Shaky A., Ray A. Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor. J Immunol 2007;178:1774-1782 (Pubitemid 46154649)
21. Bossone S.A., Asselin C., Patel A.J., Marcu K.B. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci U S A 1992;89:7452-7456
22. Ray B.K., Ray A. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 1997;36:4662-4668 (Pubitemid 27180316)
23. Ray A., Schatten H., Ray B.K. Activation of Sp1 and its functional cooperation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 1999;274:4300-4308
24. Ray A., Kumar D., Ray B.K. Promoter-binding activity of inflammation-responsive transcription factor SAF is regulated by cyclic AMP signaling pathway. DNA Cell Biol 2002;21:31-40. (Pubitemid 34253161)
25. Escot C., Theillet C., Lidereau R., Spyratos F., Champeme M.H., Gest J., et al. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci U S A 1986;83:4834-4838 (Pubitemid 16075494)
26. Wang X., Southard R.C., Allred C.D., Talbert D.R., Wilson M.E., Kilgore M.W. MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells. Breast Cancer Res Treat 2008;111:103-111 (Pubitemid 352009234)
27. Dudas J., Mansuroglu T., Moriconi F., Haller F., Wilting J., Lorf T., et al. Altered regulation of Prox1-gene-expression in liver tumors. BMC Cancer 2008;8:92.
28. Ray A., Fields A.P., Ray B.K. Activation of transcription factor SAF involves its phosphorylation by protein kinase C. J Biol Chem 2000;275:39727-39733 (Pubitemid 32059001)
29. Ray A., Yu G.Y., Ray B.K. Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway. Mol Cell Biol 2002;22:1027-1035 (Pubitemid 34094840)
30. Ray A., Ray P., Guthrie N., Shakya A., Kumar D., Ray B.K. Protein kinase A signaling pathway regulates transcriptional activity of SAF-1 by unmasking its DNA-binding domains. J Biol Chem 2003;278:22586-22595 (Pubitemid 36830315)
31. Tsutsui H., Geltinger C., Murata T., Itakura K., Wada T., Handa H., et al. The DNA-binding and transcriptional activities of MAZ, a myc-associated zinc finger protein, are regulated by casein kinase II. Bioch Biophys Res Commun 1999;262:198-205. (Pubitemid 29412647)
32. Sambrook J., Russell D.W. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001.
33. Ray A., Ray B.K. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol Cell Biol 1998;18:7327-7335 (Pubitemid 28533052)
34. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159 (Pubitemid 17064313)
35. Ray A., Bal B.S., Ray B.K. Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: Evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1. J Immunol 2005;175:4039-4048 (Pubitemid 41292067)
36. Tomisawa M., Tokunaga T., Oshika Y., Tsuchida T., Fukushima Y., Sato H., et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer 1999;35:133-137 (Pubitemid 29079504)
37. Krussel J.S., Behr B., Milki A.A., Hirchenhain J., Wen Y., Bielfeld P., et al. Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod 2001;7:57-63. (Pubitemid 32101765)
38. Ray B.K., Murphy R., Ray P., Ray A. SAF-2, a splice variant of SAF-1, acts as a negative regulator of transcription. J Biol Chem 2002;277:46822-46830 (Pubitemid 35417686)
39. Ray A., Dhar S., Shakya A., Ray P., Okada Y., Ray B.K. SAF-3, a novel splice variant of the SAF-1/MAZ/Pur-1 family, is expressed during inflammation. FEBS J 2009;276:4276-4286
40. Genestie C., Zafrani B., Asselain B., Fourquet A., Rozan S., Validire P., et al. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: Major importance of the mitotic count as a component of both grading systems. Anticancer Res 1998;18:571-576 (Pubitemid 28174874)
41. Kennedy G.C., Rutter W.J. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci U S A 1992;89:11498-11502
42. Pal S., Datta K., Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res 2001;61:6952-6957 (Pubitemid 32896524)
43. Arbiser J.L., Moses M.A., Fernandez C.A., Ghiso N., Cao Y., Klauber N., et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A 1997;94:861-866 (Pubitemid 27074412)
44. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. [erratum appears in Nature 1998 Mar 12;392(6672): 210 Note: 210 NoteGerhengorn MC [corrected to Gershengorn MC]]. Nature 1998;391:86-89
45. Wasylyk C., Imler J.L., Perez-Mutul J., Wasylyk B. The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Cell 1987;48:525-534 (Pubitemid 18095358)
46. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 1996;271:3877-3883
47. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-11954
48. Gille J., Swerlick R.A., Caughman S.W. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 1997;16:750-759 (Pubitemid 27089522)
49. Finkenzeller G., Sparacio A., Technau A., Marm E., Siemeister G. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 1997;15:669-676 (Pubitemid 27389929)
50. Gille J., Khalik M., Kaufmann R. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol 1998;111:1160-1165 (Pubitemid 29115191)
51. Schafer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., Hocker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003;278:8190-8198 (Pubitemid 36800562)
52. Bouras T., Southey M.C., Venter D.J. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001;61:903-907 (Pubitemid 32174400)
53. Wang L., Hoque A., Luo R.Z., Yuan J., Lu Z., Nishimoto A., et al. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res 2003;9:3660-3666 (Pubitemid 37169232)